Categories
Laurus Labs Limited — Updates, 30-04-2026: General Updates
30-04-2026 · 03:35 pm
Laurus Labs' Board approved investing up to €9.8 million in its pharma JV, KRKA Pharma. This, plus a €10.2 million co-venturer investment, funds a new manufacturing facility. Laurus Labs maintains its 49% stake, aligning with strategic growth plans.
No comments yet. Be the first to comment!